UK Begins Brexit Inquiry On Devices, Pharma Supplies
Executive Summary
In a busy week for Brexit watchers, the UK government has initiated an inquiry into the effects of future regulatory systems that will potentially impact medical technology and other health-care products in the UK after the country has left the EU.
You may also be interested in...
German Vote 2017: Business Must Wait As Limboland Merkel Faces Hard Coalition Choices
Germany's CDU leader Angela Merkel secured her fourth term as chancellor, but chastened by an election result that saw many of her 2013 voters turn to the liberals and far right, her hand is weakened. Indeed, the EU's rock of political stability has sprung many a surprise in delivering a 2017 election result that will give businesses a sense both of unease and promise, with the re-emergence of the liberal and business-focused FDP.
Keep Regulatory Status Quo Post-Brexit, Industry Tells Negotiators
The future regulatory outlook for the UK after the country leaves the EU has not been clear during discussions to date. Now medtech industry associations have spoken out. They warn divergence will hit patient safety and must be avoided.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.